EurekAlert!

C-Path’s pioneering neuroscience workshop transforms the landscape of neurological disorder therapies

Critical Path Institute (C-Path) is pleased to announce the release of a new peer-reviewed publication, titled “Transforming Drug Development for Neurological Disorders: Proceedings from a ...
EurekAlert!

C-Path’s translational therapeutics accelerator announces new grant award for drug development project in type 1 diabetes

TUCSON, Ariz., June 18, 2025 — Critical Path Institute’s® (C-Path) Translational Therapeutics Accelerator (TRxA) proudly announced today a $250,000 grant award aimed at developing a novel treatment ...
News Medical

C-Path announces important leadership appointments in neurology and Alzheimer's research

Critical Path Institute ® (C-Path) today announced key leadership appointments: Diane Stephenson, Ph.D., has been promoted to Vice President of Neurology, and Nadine Tatton, Ph.D., has been welcomed ...
News Medical

FDA qualifies C-Path’s DIBSS-C for clinical trials

Critical Path Institute's (C-Path) Patient-Reported Outcome (PRO) Consortium announces the qualification of the Diary for Irritable Bowel Syndrome Symptoms-Constipation (DIBSS-C) by the U.S. Food and ...
PR Newswire

C-Path's Disease Modeling Coalition Begins Global Pediatric IBD Work from European Hub

AMSTERDAM, Oct. 16, 2025 /PRNewswire/ -- Critical Path Institute ® (C-Path) today announced the official launch of the Critical Path Disease Modeling Coalition (CP-DMC) on pediatric inflammatory bowel ...